GGrantIndex
Sort

27,075 grants matching cholesterol

A New-Generation Lipid-Lowering and Anti-Inflammatory siRNA Therapy for Atherosclerosis

$787,453
Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2025 · HL

The Risk of Myocardial Infarction in Patients with Psoriasis

$787,421
Joel M Gelfand · University Of Pennsylvania · R01 · FY2009 · HL

Improving Diabetic Patients’ Adherence to Treatment and Prevention of Cardiovascular Disease

$787,388
Adesuwa B Olomu · Michigan State University · R01 · FY2020 · HL

Improving Lipid Management Strategies in Young Adults

$787,387
Yiyi Zhang · Columbia University Health Sciences · R01 · FY2023 · HL

Assessing Clinical Effectiveness and Implementation of Worksite Sleep Health Coaching in Firefighters

$787,363
Patricia Haynes · University Of Arizona · R01 · FY2024 · HL

AIBP and regulation of neuropathic pain

$787,291
Yury Miller · University Of California, San Diego · R01 · FY2019 · NS

Sterol regulation of immunometabolic responses in cardiometabolic diseases

$787,267
Carlos Fernandez Hernando · Yale University · R01 · FY2025 · HL

MTSS1 in Myocardial Disease

$787,195
Thomas P Cappola · University Of Pennsylvania · R01 · FY2019 · HL

Foam cells as drug targets in tuberculosis

$787,112
Maria Laura Gennaro · Rbhs-New Jersey Medical School · R01 · FY2022 · HL

Targeting brain myeloid cells with siRNA-lipid conjugates for treatment of Alzheimer's disease

$787,103
Ethan Lippmann · Vanderbilt University · R01 · FY2025 · AG

Gut Flora metabolism of dietary carnitine and cardiovascular disease

$786,871
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · HL

Gut Flora metabolism of dietary carnitine and cardiovascular disease

$786,871
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · HL

Gut Flora metabolism of dietary carnitine and cardiovascular disease

$786,871
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · HL

Regulation of the Endo/Lysosomal pathway

$786,870
Rosa Puertollano · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Lysosomal Diseases

$786,870
Rosa Puertollano · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Genetic and Stem Cell Model of Cardiac Metabolic Disease

$786,697
Joseph C Wu · Stanford University · R01 · FY2021 · HL

Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism

$786,684
Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA

HOME DM-BAT: Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors with T2DM

$786,069
Leonard E. Egede · Medical College Of Wisconsin · R01 · FY2021 · DK

Hypertension-associated Trained Immunity in Myeloid Cells is a Determinant of Atherosclerosis

$786,060
Amanda C Doran · Vanderbilt University Medical Center · R01 · FY2025 · HL

Gut Flora metabolism of dietary carnitine and cardiovascular disease

$786,057
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · HL

The role of signaling adaptor protein epsin in atherosclerosis

$785,922
Hong Chen · Boston Children'S Hospital · R01 · FY2023 · HL

Strengthening the HIV prevention continuum using pharmacies

$785,901
Natalie D. Crawford · Emory University · R01 · FY2023 · MH

Alzheimer Caregiver Coping: Mental and Physical Health

$785,885
Igor Grant · University Of California, San Diego · R01 · FY2007 · AG

Diet, Gut Microbiota, and Heart Failure

$785,852
Wai Hong Wilson Tang · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL

Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis

$785,723
Gary K Owens · University Of Virginia · R01 · FY2024 · HL